Organogenesis Holdings Inc (OQ:ORGO)

Business Focus: Biotechnology & Medical Research

Apr 16, 2024 07:30 am ET
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Apr 03, 2024 07:30 am ET
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
Organogenesis Holdings Inc. (NASDAQ: ORGO) a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Feb 29, 2024 04:05 pm ET
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Feb 15, 2024 11:30 pm ET
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Organogenesis Holdings, Inc. (NASDAQ: ORGO) on behalf of long-term stockholders following a class action complaint that was...
Feb 12, 2024 07:30 am ET
Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Feb 08, 2024 09:00 pm ET
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Organogenesis Holdings, Inc. (NASDAQ: ORGO) on behalf of long-term stockholders following a class action complaint that was...
Feb 08, 2024 04:05 pm ET
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Jan 01, 2024 09:00 pm ET
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Organogenesis Holdings, Inc. (NASDAQ: ORGO) on behalf of long-term stockholders following a class action complaint that was...
Dec 06, 2023 09:00 pm ET
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Organogenesis Holdings, Inc. (NASDAQ: ORGO) on behalf of long-term stockholders following a class action complaint that was filed against Organogenesis on December 10, 2021 with a Class Period from March 17, 2021 to October 11, 2021. Our investigation concerns whether the board of directors of Organogenesis have breached their fiduciary duties to the company.
Nov 10, 2023 08:31 am ET
Thinking about buying stock in Direct Digital Holdings, Organogenesis Holdings, Plug Power, Vuzix, or 2U Inc?
NEW YORK, Nov. 10, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DRCT, ORGO, PLUG, VUZI, and TWOU.
Nov 09, 2023 04:05 pm ET
Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Oct 05, 2023 07:30 am ET
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Sep 28, 2023 09:15 am ET
Organogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGS
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, applauds...
Sep 06, 2023 04:05 pm ET
Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Aug 09, 2023 04:05 pm ET
Organogenesis Holdings Inc. Reports Second Quarter 2023 Financial Results; Withdraws Fiscal Year 2023 Guidance
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Jul 10, 2023 07:30 am ET
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2023 Financial Results on August 9, 2023
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Jul 03, 2023 06:00 am ET
Bionomics Announces Key Leadership Updates to Drive U.S.-Focused Transformation and Next Stage of Strategic Growth
Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to treat patients suffering from serious central nervous system (CNS)...
May 10, 2023 04:05 pm ET
Organogenesis Holdings Inc. Reports First Quarter 2023 Financial Results
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Apr 27, 2023 07:30 am ET
Organogenesis President and Chief Executive Officer Gary S. Gillheeney, Sr. Elected Chair of the Board of Directors
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today...
Apr 10, 2023 07:30 am ET
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today...
Mar 27, 2023 08:00 am ET
Organogenesis Applauds Findings from the Office of Inspector General
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, applauds...
Mar 01, 2023 04:02 pm ET
Organogenesis Holdings Inc. Reports Fourth Quarter 2022 and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Guidance
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Mar 01, 2023 04:01 pm ET
Organogenesis Reports Positive Interim Analysis of Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today...
Feb 09, 2023 07:30 am ET
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 1, 2023
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today...
Dec 05, 2022 07:30 am ET
Organogenesis Holdings Inc. to Participate in the Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology and Medtech Conference
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today...
Nov 19, 2022 08:07 pm ET
Lifshitz Law PLLC Announces Investigations of Sleep Number Corporation (NASDAQ: SNBR), Organogenesis Holdings, Inc. (NASDAQ: ORGO), Netflix Inc. (NASDAQ: NFLX), and Mullen Automotive Inc. (NASDAQ: MUL
Sleep Number Corporation (NASDAQ: SNBR) Lifshitz Law PLLC announces that a class action complaint was filed on behalf of shareholders of Sleep Number alleging that Defendants made false and misleading statements and failed to disclose that: (i)...
Nov 09, 2022 04:05 pm ET
Organogenesis Holdings Inc. Reports Third Quarter 2022 Financial Results
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Sep 26, 2022 09:12 am ET
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2022 Financial Results on November 9, 2022
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Sep 07, 2022 07:30 am ET
Organogenesis Holdings Inc. to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today...
Aug 15, 2022 07:00 am ET
Organogenesis Receives FDA Clearance for Next Generation PuraPly Surgical Solution
Organogenesis, a leading regenerative medicine company, today announced it has received U.S. Food and Drug Administration (FDA) 510k Clearance for PuraPly MZ, a brand extension to the PuraPly product portfolio. PuraPly MZ leverages the innovative...
Aug 09, 2022 04:05 pm ET
Organogenesis Holdings Inc. Reports Second Quarter 2022 Financial Results
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Jul 14, 2022 08:35 am ET
Thinking about buying stock in Selecta Biosciences, Adial Pharmaceuticals, Exela Technologies, Theravance Biopharma, or Organogenesis?
NEW YORK, July 14, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SELB, ADIL, XELA, TBPH, and ORGO.
Jun 30, 2022 07:30 am ET
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2022 Financial Results on August 9, 2022
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
May 11, 2022 04:48 pm ET
Lifshitz Law PLLC Announces Investigations of Chegg, Inc. (NYSE: CHGG), DocuSign, Inc. (NASDAQ: DOCU), Organogenesis Holdings Inc. (NASDAQCM: ORGO), and Reata Pharmaceuticals, Inc. (NASDAQ: RETA)
-- Chegg, Inc. (NYSE: CHGG) Lifshitz Law PLLC announces that a class action complaint was filed on behalf of shareholders of Chegg alleging that the Defendants made materially false and misleading statements and failed to disclose known adverse...
May 10, 2022 04:05 pm ET
Organogenesis Holdings Inc. Reports First Quarter 2022 Financial Results
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
May 05, 2022 04:05 pm ET
Organogenesis Appoints Michele Korfin and Gilberto Quintero, Ph.D. to Board of Directors
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
May 04, 2022 04:26 pm ET
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Organogenesis Holdings Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
NEW YORK, May 4, 2022 /PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Organogenesis Holdings Inc. (NASDAQ: ORGO).
Apr 05, 2022 04:30 pm ET
Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring 2022 Conference
Organogenesis, a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that the latest advanced...
Apr 05, 2022 04:05 pm ET
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Mar 17, 2022 09:00 am ET
Organogenesis Named One of 50 Highest Growth Companies in Massachusetts by the Boston Business Journal
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, has been...
Mar 08, 2022 07:30 am ET
Organogenesis Holdings Inc. to Present at the Oppenheimer Healthcare Conference
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today...
Mar 02, 2022 08:31 am ET
Thinking about buying stock in Ford, Organogenesis, Arlo Technologies, Oil States International, or X4 Pharmaceuticals?
NEW YORK, March 2, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for F, ORGO, ARLO, OIS, and XFOR.
Mar 01, 2022 04:05 pm ET
Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2021 Financial Results; Introduces Fiscal Year 2022 Guidance
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Feb 17, 2022 04:05 pm ET
Organogenesis Appoints Michael J. Driscoll, Ed.D. to Board of Directors
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Feb 11, 2022 07:30 am ET
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today...
Feb 08, 2022 03:57 pm ET
FILING DEADLINE TODAY: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Organogenesis Holdings Inc. of Class Action Lawsuit and Upcoming Deadline – ORGO
Pomerantz LLP announces that a class action lawsuit has been filed against Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) and certain of its officers. The class action, filed in the United States District Court for...
Feb 08, 2022 05:00 am ET
ORGO ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 8, 2022 in the Class Action Filed on Behalf of Organogenesis Holdings Inc. Shareholders
NEW YORK, Feb. 8, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Organogenesis Holdings Inc. (NASDAQ: ORGO) alleging that the Company violated federal securities laws.
Feb 07, 2022 09:00 pm ET
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Revance, Paysafe, Organogenesis, and Cloopen Group and Encourages Investors to Contact
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Revance Therapeutics, Inc. (NASDAQ: RVNC), Paysafe Limited (NYSE: PSFE),...
Feb 07, 2022 08:16 am ET
Final Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Filed Against Organogenesis Holdings Inc. (ORGO)
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Organogenesis Holdings Inc....
Feb 07, 2022 07:30 am ET
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 1, 2022
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Feb 07, 2022 05:00 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Organogenesis Investors of a Lead Plaintiff Deadline of February 8, 2022
NEW YORK, Feb. 7, 2022 /PRNewswire/ -- Attention Organogenesis Holdings Inc. ("Organogenesis") (NASDAQ: ORGO) shareholders:
Feb 06, 2022 02:00 pm ET
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Organogenesis Holdings Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important February 8 Deadline in Securities Class Action – ORGO
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Organogenesis Holdings Inc. (NASDAQ: ORGO) between March 17, 2021 and October 11, 2021, inclusive (the “Class Period”), of the important February 8,...
Feb 05, 2022 06:20 pm ET
TUESDAY DEADLINE: Organogenesis Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – ORGO
Robbins Geller Rudman & Dowd LLP announces that purchasers of Organogenesis Holdings Inc. (NASDAQ: ORGO) securities between March 17, 2021 and October 11, 2021, inclusive (the “Class Period”) have until this upcoming Tuesday, February 8, 2022 to seek appointment as lead plaintiff
Feb 04, 2022 09:00 pm ET
ORGANOGENESIS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Organogenesis Holdings, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Organogenesis Holdings, Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who purchased or otherwise acquired Organogenesis securities between March 17, 2021 and October 11, 2021, both dates inclusive (the “Class Period”). Investors have until February 8, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Feb 04, 2022 03:21 pm ET
Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Organogenesis Holdings Inc.
RADNOR, Pa., Feb. 4, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis") (NASDAQ: ORGO). The action charges Organogenesis with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Organogenesis's materially misleading statements to the public, Organogenesis's investors have suffered significant losses.
Feb 04, 2022 02:06 pm ET
ORGO Deadline Alert: Bronstein, Gewirtz & Grossman, LLC, A Nationally Recognized Firm, Reminds Organogenesis Holdings Inc. Investors of Class Action and Lead Plaintiff Deadline: February 8, 2022
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO) and certain of its officers, on behalf of...
Feb 04, 2022 02:05 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Organogenesis Holdings Inc.of Class Action Lawsuit and Upcoming Deadline - ORGO
NEW YORK, Feb. 4, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO) and certain of its officers.   The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 21-cv-06845, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Organogenesis securities between March 17, 2021 and October 11, 2021, both dates inclusive (the "Class Period"), seeking to
Feb 04, 2022 12:30 pm ET
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Organogenesis Holdings Inc. (ORGO)
The Law Offices of Frank R. Cruz reminds investors of the upcoming February 8, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ:
Feb 04, 2022 05:00 am ET
ORGO SHAREHOLDER ALERT: Jakubowitz Law Reminds Organogenesis Shareholders of a Lead Plaintiff Deadline of February 8, 2022
NEW YORK, Feb. 4, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Organogenesis Holdings Inc. (NASDAQ: ORGO).
Feb 03, 2022 01:00 pm ET
DEADLINE ALERT for ORGO, XCUR, SNBR, RDW: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Feb 02, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Meta Materials, Paysafe, Organogenesis, and Marathon Digital and Encourages Investors to Contact the Fi
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Meta Materials, Inc. (NASDAQ: MMAT), Paysafe Limited (NYSE: PSFE), Organogenesis...
Feb 02, 2022 03:35 pm ET
ORGO LAWSUIT ALERT: Levi & Korsinsky Notifies Organogenesis Holdings Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Feb. 2, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO) of a class action securities lawsuit.
Feb 01, 2022 05:02 pm ET
ORGO ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 8, 2022 in the Class Action Filed on Behalf of Organogenesis Holdings Inc. Limited Shareholders
NEW YORK, Feb. 1, 2022 /PRNewswire/ --  The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Organogenesis Holdings Inc. (NASDAQ: ORGO) alleging that the Company violated federal securities laws.
Feb 01, 2022 03:31 pm ET
ORGO NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Organogenesis Holdings Inc. Investors with Losses to Secure Counsel Before Important February 8 Deadline in Securities Class Action – ORGO
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Organogenesis Holdings Inc. (NASDAQ: ORGO) between March 17, 2021 and October 11, 2021, inclusive (the “Class Period”), of the important February 8,...
Feb 01, 2022 02:00 pm ET
DEADLINE ALERT for PSFE, BFT, RVNC, RAAS, and ORGO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 31, 2022 06:19 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Organogenesis Holdings Inc. of Class Action Lawsuit and Upcoming Deadline – ORGO
Pomerantz LLP announces that a class action lawsuit has been filed against Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) and certain of its officers. The class action, filed in the United States District Court for...
Jan 31, 2022 03:22 pm ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Organogenesis Investors of a Lead Plaintiff Deadline of February 8, 2022
NEW YORK, Jan. 31, 2022 /PRNewswire/ -- Attention Organogenesis Holdings Inc. ("Organogenesis") (NASDAQ: ORGO) shareholders:
Jan 29, 2022 10:05 pm ET
DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Organogenesis Holdings Inc. of Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial
RADNOR, Pa., Jan. 29, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis") (NASDAQ: ORGO). The action charges Organogenesis with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Organogenesis's materially misleading statements to the public, Organogenesis's investors have suffered significant losses.
Jan 28, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sleep Number, Revance, Paysafe, and Organogenesis and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sleep Number Corporation (NASDAQ: SNBR), Revance Therapeutics, Inc. (NASDAQ:...
Jan 28, 2022 02:59 pm ET
ORGO Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Organogenesis Holdings Inc. Investors of Class Action
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO) and certain of its officers, on behalf of...
Jan 28, 2022 12:45 pm ET
ORGO SHAREHOLDER ALERT: Jakubowitz Law Reminds Organogenesis Shareholders of a Lead Plaintiff Deadline of February 8, 2022
NEW YORK, Jan. 28, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Organogenesis Holdings Inc. (NASDAQ: ORGO).
Jan 28, 2022 12:00 pm ET
ORGO Investors Have Opportunity to Lead Organogenesis Holdings Inc. Securities Fraud Lawsuit
BENSALEM, Pa., Jan. 28, 2022 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO).
Jan 27, 2022 09:01 pm ET
Jan 27, 2022 05:20 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Organogenesis Holdings Inc. of Class Action Lawsuit and Upcoming Deadline - ORGO
NEW YORK, Jan. 27, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO) and certain of its officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 21-cv-06845, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Organogenesis securities between March 17, 2021 and October 11, 2021, both dates inclusive (the "Class Period"), seeking to
Jan 26, 2022 06:52 pm ET
ORGO INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Reminds Investors of February 8, 2022 Deadline in Securities Fraud Class Action Lawsuit Filed Against of Organogenesis Holdings Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Organogenesis Holdings Inc....
Jan 26, 2022 11:00 am ET
DEADLINE ALERT for ORGO, XCUR, SNBR, RDW: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 25, 2022 01:00 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Organogenesis Holdings Inc. (ORGO)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 8, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Organogenesis Holdings Inc....
Jan 24, 2022 11:15 am ET
DEADLINE ALERT for PSFE, BFT, RVNC, RAAS, and ORGO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 23, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Alfi, Berkeley Lights, Organogenesis, and Paysafe and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Alfi, Inc. (NASDAQ: ALF), Berkeley Lights, Inc. (NASDAQ: BLI), Organogenesis...
Jan 23, 2022 12:43 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Organogenesis Holdings Inc. of Class Action Lawsuit and Upcoming Deadline – ORGO
Pomerantz LLP announces that a class action lawsuit has been filed against Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) and certain of its officers.   The class action, filed in the United States District Court for...
Jan 22, 2022 02:08 pm ET
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Organogenesis Holdings Inc. Investors with Losses Over $100K to Secure Counsel Before Important February 8 Deadline in Securities Class Action – ORGO
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Organogenesis Holdings Inc. (NASDAQ: ORGO) between March 17, 2021 and October 11, 2021, inclusive (the “Class Period”), of the important February 8,...
Jan 20, 2022 09:55 pm ET
CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Organogenesis Holdings Inc. Shareholders of Securities Fraud Class Action Lawsuit
RADNOR, Pa., Jan. 20, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis") (NASDAQ: ORGO). The action charges Organogenesis with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects.  As a result of Organogenesis's materially misleading statements to the public, Organogenesis's investors have suffered significant losses.
Jan 20, 2022 04:56 pm ET
Jan 20, 2022 12:00 pm ET
ORGO Investors Have Opportunity to Lead Organogenesis Holdings Inc. Securities Fraud Lawsuit
LOS ANGELES, Jan. 20, 2022 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO).
Jan 18, 2022 11:45 pm ET
DEADLINE ALERT for PSFE, BFT, RVNC, RAAS, and ORGO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 18, 2022 11:00 am ET
DEADLINE ALERT for ORGO, XCUR, SNBR, RDW: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 17, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Playtika, Alfi, Berkeley Lights, and Organogenesis and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Playtika Holdings Corp. (NASDAQ: PLTK), Alfi, Inc. (NASDAQ: ALF), Berkeley...
Jan 17, 2022 06:44 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Organogenesis Holdings Inc. of Class Action Lawsuit and Upcoming Deadline - ORGO
NEW YORK, Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO) and certain of its officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 21-cv-06845, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Organogenesis securities between March 17, 2021 and October 11, 2021, both dates inclusive (the "Class Period"), seeking to
Jan 17, 2022 11:07 am ET
Important Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Organogenesis Holdings Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Organogenesis Holdings Inc....
Jan 16, 2022 11:15 am ET
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Organogenesis Holdings Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – ORGO
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Organogenesis Holdings Inc. (NASDAQ: ORGO) between March 17, 2021 and October 11, 2021, inclusive (the “Class Period”), of the important February 8,...
Jan 13, 2022 12:48 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Organogenesis Holdings Inc. of Class Action Lawsuit and Upcoming Deadline – ORGO
Pomerantz LLP announces that a class action lawsuit has been filed against Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) and certain of its officers.  The class action, filed in the United States District Court for...
Jan 13, 2022 11:36 am ET
ORGO, XCUR & SNBR – Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Actions and Deadlines
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Jan 12, 2022 01:00 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Organogenesis Holdings Inc. (ORGO)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 8, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Organogenesis Holdings Inc....
Jan 12, 2022 08:50 am ET
ORGO Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of February 8, 2022 Deadline in Securities Fraud Class Action Lawsuit against Organogenesis Holdings Inc.
RADNOR, Pa., Jan. 12, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis") (NASDAQ: ORGO). The action charges Organogenesis with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects.  As a result of Organogenesis's materially misleading statements to the public, Organogenesis's investors have suffered significant losses.
Jan 11, 2022 11:45 am ET
DEADLINE ALERT for PSFE, BFT, RVNC, RAAS, and ORGO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 10, 2022 12:37 pm ET
Jan 10, 2022 11:15 am ET
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Organogenesis Holdings Inc. (ORGO) Investors
LOS ANGELES, Jan. 10, 2022 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO) securities between March 17, 2021 and October 11, 2021, inclusive (the "Class Period"). Organogenesis investors have until February 8, 2022 to file a lead plaintiff motion.
Jan 09, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Organogenesis, Paysafe, Revance Therapeutics, and Cloopen Group and Encourages Investors to Contact the
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Organogenesis Holdings, Inc. (NASDAQ: ORGO), Paysafe Limited (NYSE: PSFE),...
Jan 09, 2022 04:36 pm ET
Kessler Topaz Meltzer & Check, LLP: Reminds Investors of Deadline in Securities Fraud Class Action Filed Against Organogenesis Holdings Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Organogenesis Holdings Inc....
Jan 08, 2022 01:01 pm ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Organogenesis Holdings (ORGO) Investors with Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Class Action
Hagens Berman urges Organogenesis Holdings Inc. (NASDAQ: ORGO) investors with significant losses to submit your losses now. Class Period: Mar. 17, 2021 – Oct. 11, 2021Lead Plaintiff Deadline: Feb. 8, 2022Visit:...
Jan 08, 2022 11:45 am ET
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Organogenesis Holdings Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – ORGO
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Organogenesis Holdings Inc. (NASDAQ: ORGO) between March 17, 2021 and October 11, 2021, inclusive (the “Class Period”), of the important February 8,...
Jan 07, 2022 01:00 pm ET
DEADLINE ALERT for ORGO, XCUR, SNBR, RDW: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 06, 2022 05:45 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Organogenesis Holdings Inc. of Class Action Lawsuit and Upcoming Deadline - ORGO
NEW YORK, Jan. 6, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO) and certain of its officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 21-cv-06845, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Organogenesis securities between March 17, 2021 and October 11, 2021, both dates inclusive (the "Class Period"), seeking to r
Jan 06, 2022 11:35 am ET
ORGO, XCUR & SNBR – Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Actions and Deadlines
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Jan 05, 2022 11:15 am ET
DEADLINE ALERT for PSFE, BFT, RVNC, RAAS, and ORGO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 05, 2022 10:00 am ET
ORGO Investors Have Opportunity to Lead Organogenesis Holdings Inc. Securities Fraud Lawsuit
BENSALEM, Pa., Jan. 5, 2022 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO).
Jan 04, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Alfi, Berkeley Lights, and Organogenesis and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Alfi, Inc. (NASDAQ: ALF), Berkeley Lights, Inc. (NASDAQ: BLI), and Organogenesis...
Jan 04, 2022 04:06 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Organogenesis Holdings Inc. of Class Action Lawsuit and Upcoming Deadline – ORGO
Pomerantz LLP announces that a class action lawsuit has been filed against Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) and certain of its officers.   The class action, filed in the United States District Court for...
Jan 04, 2022 11:00 am ET
ORGO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Organogenesis Holdings Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Organogenesis Holdings Inc.
Jan 03, 2022 06:20 pm ET
ORGO Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of February 8, 2022 Deadline in Securities Fraud Class Action Lawsuit Filed Against Organogenesis Holdings, Inc.
RADNOR, Pa., Jan. 3, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis") (NASDAQ: ORGO). The action charges Organogenesis with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects.  As a result of Organogenesis's materially misleading statements to the public, Organogenesis's investors have suffered significant losses.
Jan 03, 2022 02:22 pm ET
ORGO LAWSUIT ALERT: Hagens Berman, National Trial Attorneys, Encourages Organogenesis Holdings (ORGO) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Class Action Filed
Hagens Berman urges Organogenesis Holdings Inc. (NASDAQ: ORGO) investors with significant losses to submit your losses now. Class Period: Mar. 17, 2021 – Oct. 11, 2021Lead Plaintiff Deadline: Feb. 8, 2022Visit:...
Jan 03, 2022 02:15 pm ET
ORGO INVESTOR NOTICE: ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Organogenesis Holdings Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action –
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Organogenesis Holdings Inc. (NASDAQ: ORGO) between March 17, 2021 and October 11, 2021, inclusive (the “Class Period”), of the important February 8,...
Jan 03, 2022 01:35 pm ET
Jan 01, 2022 05:11 pm ET
Investor Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against of Organogenesis Holdings Inc. (ORGO)
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Organogenesis Holdings Inc....
Dec 31, 2021 01:40 pm ET
UPCOMING DEADLINE ALERT: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, Dec. 31, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Organogenesis Holdings Inc. ("Organogenesis" or "the Company") (NASDAQ: ORGO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Dec 30, 2021 12:50 pm ET
DEADLINE ALERT for RVNC, RAAS, ORGO, and XCUR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Dec 30, 2021 11:34 am ET
ORGO, XCUR & SNBR – Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Actions and Lead Deadlines
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Dec 29, 2021 10:35 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Organogenesis Holdings Inc. of Class Action Lawsuit and Upcoming Deadline - ORGO
NEW YORK, Dec. 29, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO) and certain of its officers.  The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 21-cv-06845, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Organogenesis securities between March 17, 2021 and October 11, 2021, both dates inclusive (the "Class Period"), seeking to
Dec 29, 2021 10:27 pm ET
ALERT: Organogenesis Holdings Inc. Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit - ORGO
SAN DIEGO, Dec. 29, 2021 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Organogenesis Holdings Inc. (NASDAQ: ORGO) securities between March 17, 2021 and October 11, 2021, both dates inclusive (the "Class Period") have until February 8, 2022 to seek appointment as lead plaintiff in Somogyi v. Organogenesis Holdings Inc., No. 21-cv-06845 (E.D.N.Y.).  Commenced on December 10, 2021 and pending before Judge Diane Gujarati, the Organogenesis class action lawsuit charges Organogenesis along with certain of its top executives with violations of the
Dec 29, 2021 10:25 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Organogenesis Holdings Inc. of Class Action Lawsuit and Upcoming Deadline - ORGO
NEW YORK, Dec. 29, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO) and certain of its officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 21-cv-06845, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Organogenesis securities between March 17, 2021 and October 11, 2021, both dates inclusive (the "Class Period"), seeking to
Dec 29, 2021 02:11 pm ET
LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors With Substantial Losses to Contact the Firm
SAN DIEGO, Dec. 29, 2021 /PRNewswire/ -- Johnson Fistel, LLP, announces that class action lawsuits have commenced on behalf of shareholders of the publicly traded companies listed below. The Private Securities Litigation Reform Act of 1995 permits any investor who purchased common stock during the Class Period to seek appointment as lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation.  The lead plaintiff can select a law firm of its choice.  An investor's ability to share in any potential future recovery is not dependent upon serving as lead
Dec 29, 2021 10:00 am ET
DEADLINE ALERT for ORGO, XCUR, SNBR, RDW: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Dec 28, 2021 02:45 pm ET
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Organogenesis Holdings Inc. Investors with Losses to Secure Counsel Before Important February 8 Deadline in Securities Class Action – ORGO
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Organogenesis Holdings Inc. (NASDAQ: ORGO) between March 17, 2021 and October 11, 2021, inclusive (the “Class Period”), of the important February 8,...
Dec 28, 2021 09:59 am ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Organogenesis Holdings (ORGO) Investors to Securities Fraud Class Action, Encourages Investors with Losses to Contact Firm’s Attorneys
Hagens Berman urges Organogenesis Holdings Inc. (NASDAQ: ORGO) investors with significant losses to submit your losses now. Class Period: Mar. 17, 2021 – Oct. 11, 2021Lead Plaintiff Deadline: Feb. 8, 2022Visit: www.hbsslaw.com/investor-fraud/ORGO...
Dec 27, 2021 01:20 pm ET
Dec 27, 2021 12:00 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Organogenesis Holdings Inc. (ORGO)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 8, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ:
Dec 25, 2021 07:10 pm ET
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Organogenesis Holdings Inc.
RADNOR, Pa., Dec. 25, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis") (NASDAQ: ORGO). The action charges Organogenesis with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects.  As a result of Organogenesis's materially misleading statements to the public, Organogenesis's investors have suffered significant losses.
Dec 24, 2021 09:00 pm ET
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Organogenesis Holdings, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Organogenesis Holdings, Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) in the United States...
Dec 24, 2021 04:16 pm ET
ROSEN, A TOP RANKED FIRM, Encourages Organogenesis Holdings Inc. Investors to Secure Counsel Before Important February 8 Deadline in Securities Class Action – ORGO
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Organogenesis Holdings Inc. (NASDAQ: ORGO) between March 17, 2021 and October 11, 2021, inclusive (the “Class Period”), of the important February 8,...
Dec 24, 2021 10:11 am ET
Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against Organogenesis Holdings Inc. (ORGO)
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Organogenesis Holdings Inc....
Dec 23, 2021 12:45 pm ET
Lifshitz Law Firm, P.C. Announces Investigations of Cloopen Group Holding Limited (NYSE: RAAS), Exicure, Inc. (NASDAQCM: XCUR), Organogenesis Holdings Inc. (NASDAQCM: ORGO), and Sleep Number Corporati
Cloopen Group Holding Limited (NYSE: RAAS) Lifshitz Law Firm, P.C. announces that a class action complaint was filed against RAAS alleging that the Registration Statement issued in connection with the IPO contained materially false and...
Dec 23, 2021 10:10 am ET
ORGO INVESTOR FRAUD: Hagens Berman, National Trial Attorneys, Encourages Organogenesis Holdings (ORGO) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Class Action File
Hagens Berman urges Organogenesis Holdings Inc. (NASDAQ: ORGO) investors with significant losses to submit your losses now. Class Period:Mar. 17, 2021 – Oct. 11, 2021Lead Plaintiff Deadline:Feb. 8,...
Dec 22, 2021 02:31 pm ET
DEADLINE ALERT for RVNC, RAAS, ORGO, and XCUR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Dec 22, 2021 11:00 am ET
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Organogenesis Holdings Inc. (ORGO)
Law Offices of Howard G. Smith reminds investors of the upcoming February 8, 2022 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) securities between March 17, 2021 and October 11, 2021, inclusive (the “Class Pe
Dec 21, 2021 06:20 pm ET
Dec 21, 2021 06:18 pm ET
Dec 21, 2021 06:02 am ET
ORGO Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against Organogenesis Holdings, Inc. (ORGO)
Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Organogenesis Holdings, Inc. (NASDAQ: ORGO) securities between March 17, 2021 and October 11, 2021, for violations of the Securities Exchange Act of 1934. Orga
Dec 20, 2021 11:00 am ET
ORGO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Organogenesis Holdings Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Organogenesis securities between March 17, 2021 and October 11, 2021, (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site:
Dec 20, 2021 10:00 am ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Organogenesis Holdings Inc. (ORGO) Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ:
Dec 19, 2021 09:00 pm ET
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Organogenesis Holdings, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Organogenesis Holdings, Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) in the United States...
Dec 18, 2021 09:55 am ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Organogenesis Holdings (ORGO) Investors with Substantial Losses to Contact Firm’s Attorneys Now, Deadline Approaching in Securities Class Action
Hagens Berman urges Organogenesis Holdings Inc. (NASDAQ: ORGO) investors with significant losses to submit your losses now. Class Period: Mar. 17, 2021 – Oct. 11, 2021Lead Plaintiff Deadline: Feb. 8, 2022Visit:...
Dec 17, 2021 05:11 pm ET
Kessler Topaz Meltzer & Check, LLP: Reminds Investors of Securities Fraud Class Action Filed Against Organogenesis Holdings Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Organogenesis Holdings Inc. (“Organogenesis”) (
Dec 17, 2021 04:30 pm ET
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Organogenesis Holdings Inc. Investors to Secure Counsel Before Important February 8 Deadline in Securities Class Action – ORGO
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Organogenesis Holdings Inc. (NASDAQ: ORGO) between March 17, 2021 and October 11, 2021, inclusive (the “Class Period”), of the important February 8, 2022 lead plaintiff deadline.
Dec 17, 2021 01:00 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Organogenesis Holdings Inc. (ORGO) Investors
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) securities between March 17, 2021 and October 11, 2021, inclusive (the “Class Period”). Organogenesis investors have until February 8, 2022
Dec 17, 2021 11:20 am ET
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Organogenesis Holdings Inc. (ORGO) Investors
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ:
Dec 16, 2021 10:53 pm ET
ORGO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Organogenesis Holdings Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO) and certain of its officers, on behalf...
Dec 16, 2021 04:15 pm ET
ORGO SHAREHOLDER ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Organogenesis Holdings Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – ORGO
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Organogenesis Holdings Inc. (NASDAQ: ORGO) between March 17, 2021 and October 11, 2021, inclusive (the...
Dec 16, 2021 12:00 pm ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Organogenesis Holdings Inc. (ORGO) on Behalf of Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ:
Dec 16, 2021 10:00 am ET
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Organogenesis Holdings Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
NEW YORK, Dec. 16, 2021 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Organogenesis Holdings Inc. (NASDAQ: ORGO).
Dec 16, 2021 07:50 am ET
Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Organogenesis Holdings Inc. (ORGO)
RADNOR, Pa., Dec. 16, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis") (NASDAQ: ORGO). The action charges Organogenesis with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects.  As a result of Organogenesis's materially misleading statements to the public, Organogenesis's investors have suffered significant losses.
Dec 15, 2021 03:37 pm ET
Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Filed Against Organogenesis Holdings Inc. - ORGO
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Organogenesis Holdings Inc....
Dec 15, 2021 12:38 pm ET
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Organogenesis Holdings Inc. (ORGO)
Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) in the United States District Court for the Eastern District of New York on behalf...
Dec 15, 2021 12:00 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Organogenesis Holdings Inc. (ORGO) on Behalf of Investors
Law Offices of Howard G. Smith announces an investigation on behalf of Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) investors concerning the Company’s possible violations of federal securities laws.
Dec 15, 2021 11:34 am ET
ORGO SHAREHOLDERS: Robbins LLP Informs Investors of Class Action Against Organogenesis Holdings, Inc. (ORGO)
Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Organogenesis Holdings, Inc. (NASDAQ: ORGO) securities between March 17, 2021 and October 11, 2021, for violations of the Securities Exchange Act of 1934. Organogenesis is a reg
Dec 14, 2021 10:23 pm ET
DEADLINE: Organogenesis Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ORGO
SAN DIEGO, Dec. 14, 2021 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Organogenesis Holdings Inc. (NASDAQ: ORGO) securities between March 17, 2021 and October 11, 2021, inclusive (the "Class Period") have until February 8, 2022 to seek appointment as lead plaintiff in Somogyi v. Organogenesis Holdings Inc., No. 21-cv-06845 (E.D.N.Y.).  Commenced on December 10, 2021, the Organogenesis class action lawsuit charges Organogenesis along with certain of its top executives with violations of the Securities Exchange Act of 1934. 
Dec 14, 2021 09:30 am ET
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Organogenesis Holdings Inc. (“Organogenesis” or “the Company”) (NASDAQ:
Dec 14, 2021 09:16 am ET
ORGO INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Organogenesis Holdings (ORGO) Investors with Substantial Losses to Contact Firm's Attorneys Now, Securities Fraud Class Action
SAN FRANCISCO, Dec. 14, 2021 /PRNewswire/ -- Hagens Berman urges Organogenesis Holdings Inc. (NASDAQ: ORGO) investors with significant losses to submit your losses now. 
Dec 14, 2021 09:00 am ET
ORGO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Organogenesis Holdings Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
NEW YORK, Dec. 14, 2021 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Organogenesis Holdings Inc.
Dec 13, 2021 09:20 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Organogenesis Holdings Inc. of Class Action Lawsuit and Upcoming Deadline - ORGO
NEW YORK, Dec. 13, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO) and certain of its officers.  The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 21-cv-06845, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Organogenesis securities between March 17, 2021 and October 11, 2021, both dates inclusive (the "Class Period"), seeking to
Dec 13, 2021 05:20 pm ET
Dec 13, 2021 03:57 pm ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Organogenesis Holdings Inc. (“Organogenesis” or “the Company”) (NASDAQ:
Dec 13, 2021 03:48 pm ET
ALERT: Organogenesis Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ORGO
Robbins Geller Rudman & Dowd LLP announces that purchasers of Organogenesis Holdings Inc. (NASDAQ: ORGO) securities between March 17, 2021 and October 11, 2021, inclusive (the “Class Period”) have until February 8, 2021 to seek appointment as lead plaintiff in Somogyi v. Organ
Dec 13, 2021 12:44 pm ET
EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages Organogenesis Holdings Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ORGO
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Organogenesis Holdings Inc. (NASDAQ: ORGO) between March 17, 2021 and October 11, 2021, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 8, 2022.
Dec 13, 2021 05:00 am ET
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Organogenesis Holdings, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Organogenesis Holdings, Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who purchased or otherwise acquired Organogenesis securities between March 17, 2021 and October 11, 2021, both dates inclusive (the “Class Period”). Investors have until February 8, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Dec 12, 2021 09:00 pm ET
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Organogenesis Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Organogenesis Holdings, Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) on behalf of Organogenesis stockholders. Our...
Dec 10, 2021 10:06 pm ET
Pomerantz Law Firm Announces the Filing of a Class Action Against Organogenesis Holdings Inc. and Certain Officers – ORGO
Pomerantz LLP announces that a class action lawsuit has been filed against Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) and certain of its officers. The class action, filed in the United States District Court for...
Dec 10, 2021 09:00 pm ET
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Organogenesis Holdings, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Organogenesis Holdings, Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) in the United States...
Dec 07, 2021 09:00 pm ET
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Organogenesis Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Organogenesis Holdings, Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) on behalf of Organogenesis stockholders. Our...
Dec 05, 2021 07:35 am ET
Investigation Alert: Did You Lose Money on Your Investment? Johnson Fistel, LLP Encourages Investors to Contact the Firm
SAN DIEGO, Dec. 5, 2021 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP, is investigating potential claims against the following Companies for violations of federal securities laws.
Dec 02, 2021 09:00 pm ET
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Organogenesis Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Organogenesis Holdings, Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) on behalf of Organogenesis stockholders. Our...
Nov 27, 2021 05:00 am ET
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Organogenesis Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Organogenesis Holdings, Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) on behalf of Organogenesis stockholders. Our...
Nov 22, 2021 07:00 am ET
Organogenesis Appoints Prathyusha Duraibabu to Board of Directors
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Nov 20, 2021 09:54 am ET
Investigation Alert: Did You Lose Money on Your Investment? Johnson Fistel, LLP Encourages Investors to Contact the Firm
SAN DIEGO, Nov. 20, 2021 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP, is investigating potential claims against the following Companies for violations of federal securities laws.
Nov 17, 2021 11:30 pm ET
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Organogenesis Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Organogenesis Holdings, Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) on behalf of Organogenesis stockholders. Our investigation concerns whether Organogenesis has violated the federal securities laws and/or engaged in other unlawful business practices.
Nov 09, 2021 04:05 pm ET
Organogenesis Holdings Inc. Reports Third Quarter and First Nine Months 2021 Financial Results
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Nov 08, 2021 07:30 am ET
Organogenesis Holdings Inc. to Participate in the Credit Suisse 30th Annual Healthcare Conference
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today...
Nov 04, 2021 02:46 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
NEW YORK, Nov. 4, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO).  Such investors are advised to contact Robert S. Willoughby at  [email protected] or 888-476-6529, ext. 7980.
Nov 01, 2021 04:29 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO).   Such investors are advised to contact Robert S. Willoughby at  [email protected] or 888-476-6529,...
Nov 01, 2021 09:39 am ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Organogenesis Holdings (ORGO) Investors with Substantial Losses to Contact Firm’s Attorneys Now, Firm Investigating Possible Securities Law Violatio
Hagens Berman urges Organogenesis Holdings Inc. (NASDAQ: ORGO) investors with significant losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/ORGOContact An Attorney Now: [email protected] 844-916-0895 Organogenesis...
Oct 27, 2021 09:25 am ET
Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Fall 2021 Conference
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Oct 26, 2021 01:02 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
NEW YORK, Oct. 26, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Oct 25, 2021 06:11 pm ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Organogenesis Holdings (ORGO) Investors with Significant Losses to Contact Firm’s Attorneys Now, Firm Investigating Possible Securities Law Violatio
Hagens Berman urges Organogenesis Holdings Inc. (NASDAQ: ORGO) investors with significant losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/ORGOContact An Attorney Now: [email protected] 844-916-0895 Organogenesis Holdings Inc....
Oct 25, 2021 12:15 pm ET
The Law Offices of Frank R. Cruz Announces Investigation of Organogenesis Holdings Inc. (ORGO) on Behalf of Investors
The Law Offices of Frank R. Cruz announces an investigation of Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ:
Oct 21, 2021 09:30 am ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Organogenesis Holdings (ORGO) Investors with Significant Losses to Contact Firm's Attorneys Now, Firm Investigating Possible Securities Law Violatio
SAN FRANCISCO, Oct. 21, 2021 /PRNewswire/ -- Hagens Berman urges Organogenesis Holdings Inc. (NASDAQ: ORGO) investors with significant losses to submit your losses now. 
Oct 20, 2021 07:27 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext....
Oct 20, 2021 04:00 pm ET
ORGANOGENESIS INVESTIGATION: Block & Leviton Is Investigating Organogenesis Holdings, Inc. For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
Block & Leviton is investigating Organogenesis Holdings, Inc. (NASDAQ: ORGO) for potential securities law violations. Investors who have lost money in their Organogenesis Holdings, Inc. investment should contact the firm to learn more about how...
Oct 20, 2021 02:51 pm ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Organogenesis Holdings (ORGO) Investors with Significant Losses to Contact Firm’s Attorneys Now, Firm Investigating Possible Securities Law Violatio
Hagens Berman urges Organogenesis Holdings Inc. (NASDAQ: ORGO) investors with significant losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/ORGO Contact An Attorney Now: [email protected] 844-916-0895 Organogenesis Holdings...
Oct 15, 2021 09:00 pm ET
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Organogenesis Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Organogenesis Holdings, Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) on behalf of Organogenesis stockholders. Our investigation concerns whether Organogenesis has violated the federal securities laws and/or engaged in other unlawful business practices.
Oct 15, 2021 08:46 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
NEW YORK, Oct. 15, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO).  Such investors are advised to contact Robert S. Willoughby at  [email protected] or 888-476-6529, ext. 7980.
Oct 15, 2021 05:56 pm ET
OrganoGenesis Holdings Investors: Company Investigated by the Portnoy Law Firm
The Portnoy Law Firm advises OrganoGenesis Holdings ("OrganoGenesis" or the "Company") (NASDAQ: ORGO) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors....
Oct 15, 2021 12:00 pm ET
Investigation Notice: The Schall Law Firm Announces it is Investigating Claims Against Organogenesis Holdings Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, Oct. 15, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Organogenesis Holdings Inc. ("Organogenesis" or "the Company") (NASDAQ: ORGO) for violations of the securities laws.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.